OncologyTube Professional - Patients Click Here
1,540,026 video views
IMEDEX: Videos
21:12
Earn CME: https://nacc... In this presentation from the 'Updates on Treatment Approaches Across the Multiple Myeloma Spectrum' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Noopur Raje provides an update on the standard of care for maintenance therapy in patients with multiple myel...
by:imedex | 155 views
24:42
Earn CME: https://nacc... In this presentation from the 'Updates on Treatment Approaches Across the Multiple Myeloma Spectrum' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Jonathan L. Kaufman provides an update on first line therapy for multiple myeloma. © 2019 Imedex, an HMP C...
by:imedex | 91 views
19:22
Earn CME: https://nacc... In this presentation from the 'Updates on Treatment Approaches Across the Multiple Myeloma Spectrum' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Thomas G. Martin discusses emerging immunotherapies for the treatment of multiple myeloma. © 2019 Imedex, ...
by:imedex | 76 views
14:25
Earn CME: https://nacc... In this presentation from the 'Updates on Treatment Approaches Across the Multiple Myeloma Spectrum' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Saad Z. Usmani discusses recent advances in small molecule inhibition for the treatment of multiple myeloma. ...
by:imedex | 47 views
50:21
Earn CME credit: https://www.... PARP inhibitors are the most commonly used targeted therapy for patients with recurrent ovarian cancer, and the indications for the use of these drugs have expanded in recent months. This roundtable discussion between Dr. Robert L. C...
by:imedex | 37 views
25:28
Earn CME Credit: https://www.... Knowledge is evolving regarding numerous clinical aspects of immune thrombocytopeni​c purpura (ITP), and there remains significant variability in clinical practice patterns for its management. This activity features Drs. David P. Steensma and Ilene C. Weitz sharing their insights about data rec...
by:imedex | 31 views
40:26
Earn CME credit for this activity: https://www.... With a focus on integrating recent advances into improved care pathways, this on-demand webcast features a presentation on the latest treatment options, current guidelines, available cost data, and expert recommendation...
by:imedex | 287 views
37:22
Earn CME credit for this activity: https://www.... This on-demand webcast examines the efficacy and safety, indications, and cost utility of available EGFR tyrosine kinase inhibitors (TKIs) and monoclonal antibodies into optimal first-line selection and NSCLC pathway pl...
by:imedex | 352 views
52:19
Earn CME credit for this activity: https://www.... This on-demand webcast examines the latest clinical and pharmacoeconomi​c data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway pl...
by:imedex | 335 views
29:50
Earn CME credit for this activity: https://www.... This on-demand activity examines the implications of BRCA mutational status, BRCAness, synthetic lethality, and within-class differences in the mechanisms of action, efficacy and safety, and indications of available and...
by:imedex | 269 views
dsfsd